USANA Health (DE:USJ)
FRANKFURT:USJ
Want to see DE:USJ full AI Analyst Report?
USJ Stock Chart & Stats
€18.40
-€0.40(-1.19%)
At close: 4:00 PM EST
€18.40
-€0.40(-1.19%)
Day’s Range― - ―
52-Week Range€14.10 - €29.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€324.31M
Enterprise Value€213.13M
Total Cash (Recent Filing)€158.38M
Total Debt (Recent Filing)€14.00M
Price to Earnings (P/E)33.6
Beta0.77
Next Earnings
May 05, 2026EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.51
Shares Outstanding18,456,936
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.7
Revenue Forecast (FY)€802.33M
Bulls Say, Bears Say
Bulls Say
Low Leverage, Strong Balance SheetUSANA's very low debt-to-equity provides durable financial flexibility to fund retail rollouts, absorb cyclical volatility, and support R&D or manufacturing initiatives without relying on costly external financing. This lowers solvency risk and sustains strategic optionality through execution cycles.
Retail & Distribution Wins For Venture BrandsSecuring Target and Costco placements materially diversifies go-to-market beyond direct selling, giving venture brands scalable retail channels. Persistent retail distribution can structurally increase brand reach, recurring shelf presence, and reduces single-channel dependence over the medium term.
High Gross Margins Indicate Product StrengthSustained gross margins near 80% imply durable product economics and pricing power in supplements/personal care. Combined with third‑party quality recognition (ConsumerLab Seal), this supports long-term brand trust and the ability to absorb marketing or channel investments while preserving core unit economics.
Bears Say
Material Free Cash Flow DeclineA ~54% drop in free cash flow reduces internal funding for inventory build, retail launches, or tech modernization without external capital. Lower cash conversion heightens execution risk, constrains discretionary investment, and increases sensitivity to margin or sales shocks over the next several quarters.
Sharp Profitability CompressionNet margin compression to ~1.2% signals compromised earnings power despite strong gross margins, reflecting higher SG&A, venture mix, and tax impacts. Persistently low net margins limit reinvestment, depress returns on equity, and make earnings highly sensitive to modest revenue or cost swings.
Elevated Inventory And Working-capital RiskA $35M, 48% inventory build ties up cash and raises risk of markdowns or write-offs if retail uptake lags. Sustained high inventories increase carrying costs and working-capital needs, constraining liquidity and amplifying execution risk during retail rollouts over the medium term.
USANA Health News
USJ FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was €14.10 and its highest was €29.60 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is €324.31M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is May 05, 2026 which is in 13 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Feb 17, 2026. The company reported €0.511 earnings per share for the quarter, beating the consensus estimate of €0.349 by €0.162.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.37.
How many shares outstanding does USANA Health have?
USANA Health has 18,456,936 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of €0.511 in its last earnings report, beating expectations of €0.349. Following the earnings report the stock price went up 4.734%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in DE:USJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:USJ Sentiment 75%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $201.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
2.03%
Trailing 12-Months
Asset Growth
-0.71%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
USJ Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive outlook: clear positives include retail wins for Hiya and Rise Wellness, a 4% midpoint sales growth outlook for FY2026, experienced leadership returning to CEO, and cost savings from workforce realignment. Offsetting these positives are meaningful risks — notably a 48% inventory build, a very high effective tax rate guidance of 55–60%, core-business sales declines, and FY2026 margin pressure from venture-brand mix with Rise only expected to breakeven. Management conveyed confidence and a concrete strategic plan, but several financial and execution risks remain that balance the positive operational developments.View all DE:USJ earnings summariesTechnical Analysis
Herbalife
―
Lifeway Foods
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―
Options Prices
Currently, No data available
---